Results: 1-25 | 26-50 | 51-75 | 76-100 | >>

Table of contents of journal: *Journal of clinical oncology

Results: 76-100/4838

Authors: Hartmann, JT Einhorn, L Nichols, CR Droz, JP Horwich, A Gerl, A Fossa, SD Beyer, J Pont, J Schmoll, HJ Kanz, L Bokemeyer, C
Citation: Jt. Hartmann et al., Second-line chemotherapy in patients with relapsed extragonadal nonseminomatous germ cell tumors: Results of an international multicenter analysis, J CL ONCOL, 19(6), 2001, pp. 1641-1648

Authors: Zisman, A Pantuck, AJ Dorey, F Said, JW Shvarts, O Quintana, D Gitlitz, BJ deKernion, JB Figlin, RA Belldegrun, AS
Citation: A. Zisman et al., Improved prognostication of renal cell carcinoma using an integrated staging system, J CL ONCOL, 19(6), 2001, pp. 1649-1657

Authors: Shotland, LI Ondrey, FG Mayo, KA Viner, JL
Citation: Li. Shotland et al., Recommendations for cancer prevention trials using potentially ototoxic test agents, J CL ONCOL, 19(6), 2001, pp. 1658-1663

Authors: Camerini, T Mariani, L De Palo, G Marubini, E Di Mauro, MG Decensi, A Costa, A Veronesi, U
Citation: T. Camerini et al., Safety of the synthetic retinoid fenretinide: Long-term results from a controlled clinical trial for the prevention of contralateral breast cancer, J CL ONCOL, 19(6), 2001, pp. 1664-1670

Authors: Gelber, S Coates, AS Goldhirsch, A Castiglione-Gertsch, M Marini, G Lindtner, J Edelmann, DZ Gudgeon, A Harvey, V Gelber, RD
Citation: S. Gelber et al., Effect of pregnancy on overall survival after the diagnosis of early-stagebreast cancer, J CL ONCOL, 19(6), 2001, pp. 1671-1675

Authors: Molenaar, S Sprangers, MAG Rutgers, EJT Luiten, EJT Mulder, J Bossuyt, PMM van Everdingen, JJE Oosterveld, P de Haes, HCJM
Citation: S. Molenaar et al., Decision support for patients with early-stage breast cancer: Effects of an interactive breast cancer CDROM on treatment decision, satisfaction, and quality of life, J CL ONCOL, 19(6), 2001, pp. 1676-1687

Authors: Voogd, AC Nielsen, M Peterse, JL Blichert-Toft, M Bartelink, H Overgaard, M van Tienhoven, G Andersen, KW Sylvester, RJ van Dongen, JA
Citation: Ac. Voogd et al., Differences in risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage I and II breast cancer: Pooled results of two large European randomized trials, J CL ONCOL, 19(6), 2001, pp. 1688-1697

Authors: Harris, LN Liotcheva, V Broadwater, G Ramirez, MJ Maimonis, P Anderson, S Everett, T Harpole, D Moore, MB Berry, DA Rizzeri, D Vredenburgh, JJ Bentley, RC
Citation: Ln. Harris et al., Comparison of methods of measuring HER-2 in metastatic breast cancer patients treated with high-dose chemotherapy, J CL ONCOL, 19(6), 2001, pp. 1698-1706

Authors: Jassem, J Pienkowski, T Pluzanska, A Jelic, S Gorbunova, V Mrsic-Krmpotic, Z Berzins, J Nagykalnai, T Wigler, N Renard, J Munier, S Weil, C
Citation: J. Jassem et al., Doxorubicin and paclitaxel versus fluorouracil, doxorubicin, and cyclophosphamide as first-line therapy for women with metastatic breast cancer: Final results of a randomized phase III multicenter trial, J CL ONCOL, 19(6), 2001, pp. 1707-1715

Authors: Rivera, E Valero, V Syrewicz, L Rahman, Z Esteva, FL Theriault, RL Rosales, MM Booser, D Murray, JL Bast, RC Hortobagyi, GN
Citation: E. Rivera et al., Phase I study of stealth liposomal doxorubicin in combination with gemcitabine in the treatment of patients with metastatic breast cancer, J CL ONCOL, 19(6), 2001, pp. 1716-1722

Authors: Reinhold, U Berkin, C Bosserhoff, AK Deutschmann, A Garbe, C Glaser, R Hein, R Krahn, G Peter, RU Rappl, G Schittek, B Seiter, S Ugurel, S Volkenandt, M Tilgen, W
Citation: U. Reinhold et al., Interlaboratory evaluation of a new reverse transcriptase polymerase chainreaction-based enzyme-linked immunosorbent assay for the detection of circulating melanoma cells: A multicenter study of the dermatologic cooperativeoncology group, J CL ONCOL, 19(6), 2001, pp. 1723-1727

Authors: Lara, PN Higdon, R Lim, N Kwan, K Tanaka, M Lau, DHM Wun, T Welborn, J Meyers, FJ Christensen, S O'Donnell, R Richman, C Scudder, SA Tuscano, J Gandara, DR Lam, KS
Citation: Pn. Lara et al., Prospective evaluation of cancer clinical trial accrual patterns: Identifying potential barriers to enrollment, J CL ONCOL, 19(6), 2001, pp. 1728-1733

Authors: Breathnach, OS Freidlin, B Conley, B Green, MR Johnson, DH Gandara, DR O'Connell, M Shepherd, FA Johnson, BE
Citation: Os. Breathnach et al., Twenty-two years of phase III trials for patients with advanced non-small-cell lung cancer: Sobering results, J CL ONCOL, 19(6), 2001, pp. 1734-1742

Authors: von Pawel, J Gatzemeier, U Pujol, JL Moreau, L Bildat, S Ranson, M Richardson, G Steppert, C Riviere, A Camlett, I Lane, S Ross, G
Citation: J. Von Pawel et al., Phase II comparator study of oral versus intravenous topotecan in patientswith chemosensitive small-cell lung cancer, J CL ONCOL, 19(6), 2001, pp. 1743-1749

Authors: Schuler, M Herrmann, R De Greve, JLP Stewart, AK Gatzemeier, U Stewart, DJ Laufman, L Gralla, R Kuball, J Buhl, R Heussel, CP Kommoss, F Perruchoud, AP Shepherd, FA Fritz, MA Horowitz, JA Huber, C Rochlitz, C
Citation: M. Schuler et al., Adenovirus-mediated wild-type p53 gene transfer in patients receiving chemotherapy for advanced non-small-cell lung cancer: Results of a multicenter phase II study, J CL ONCOL, 19(6), 2001, pp. 1750-1758

Authors: Campos, D Pereira, JR Reinhardt, RR Carracedo, C Poli, S Vogel, C Martinez-Cedillo, J Erazo, A Wittreich, J Eriksson, LO Carides, AD Gertz, BJ
Citation: D. Campos et al., Prevention of cisplatin-induced emesis by the oral neurokinin-1 antagonist, MK-869, in combination with granisetron and dexamethasone or with dexamethasone alone, J CL ONCOL, 19(6), 2001, pp. 1759-1767

Authors: Leighl, N Gattellari, M Butow, P Brown, R Tattersall, MHN
Citation: N. Leighl et al., Discussing adjuvant cancer therapy, J CL ONCOL, 19(6), 2001, pp. 1768-1778

Authors: Villafranca, E Okruzhnov, Y Dominguez, MA Garcia-Foncillas, J Azinovic, I Martinez, E Ilarramendi, JJ Arias, F Monge, RM Salgado, E Angeletti, S Brugarolas, A
Citation: E. Villafranca et al., Polymorphisms of the repeated sequences in the enhancer region of the thymidylate synthase gene promoter may predict downstaging after preoperative chemoradiation in rectal cancer, J CL ONCOL, 19(6), 2001, pp. 1779-1786

Authors: Porschen, R Bermann, A Loffler, T Haack, G Rettig, K Anger, Y Strohmeyer, G
Citation: R. Porschen et al., Fluorouracil plus leucovorin as effective adjuvant chemotherapy in curatively resected stage III colon cancer: Results of the trial adjCCA-01, J CL ONCOL, 19(6), 2001, pp. 1787-1794

Authors: Burchill, SA Lewis, IJ Abrams, KR Riley, R Imeson, J Pearson, ADJ Pinkerton, R Selby, P
Citation: Sa. Burchill et al., Circulating neuroblastoma cells detected by reverse transcriptase polymerase chain reaction for tyrosine hydroxylase mRNA are an independent poor prognostic indicator in stage 4 neuroblastoma in children over 1 year, J CL ONCOL, 19(6), 2001, pp. 1795-1801

Authors: Thompson, SJ Leigh, L Christensen, R Xiong, XP Kun, LE Heideman, RL Reddick, WE Gajjar, A Merchant, T Pui, CH Hudson, MM Mulhern, RK
Citation: Sj. Thompson et al., Immediate neurocognitive effects of methylphenidate on learning-impaired survivors of childhood cancer, J CL ONCOL, 19(6), 2001, pp. 1802-1808

Authors: Basen-Engquist, K Bodurka-Bevers, D Fitzgerad, MA Webster, K Cella, D Hu, SH Gershenson, DM
Citation: K. Basen-engquist et al., Reliability and validity of the functional assessment of cancer therapy-ovarian, J CL ONCOL, 19(6), 2001, pp. 1809-1817

Authors: Paulussen, M Ahrens, S Dunst, J Winkelmann, W Exner, GU Kotz, R Amann, G Dockhorn-Dworniczak, B Harms, D Muller-Weihrich, S Welte, K Kornhuber, B Janka-Schaub, G Gobel, U Treuner, J Voute, PA Zoubek, A Gadner, H Jurgens, H
Citation: M. Paulussen et al., Localized Ewing tumor of bone: Final results of the cooperative Ewing's Sarcoma Study CESS 86, J CL ONCOL, 19(6), 2001, pp. 1818-1829

Authors: Pisters, KMW Newman, RA Coldman, B Shin, DM Khuri, FR Hong, WK Glisson, BS Lee, JS
Citation: Kmw. Pisters et al., Phase I trial of oral green tea extract in adult patients with solid tumors, J CL ONCOL, 19(6), 2001, pp. 1830-1838

Authors: Sharma, S White, D Imondi, AR Placke, ME Vail, DM Kris, MG
Citation: S. Sharma et al., Development of inhalational agents for oncologic use, J CL ONCOL, 19(6), 2001, pp. 1839-1847
Risultati: 1-25 | 26-50 | 51-75 | 76-100 | >>